MENU
MRUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Merus (MRUS) Ownership - Who owns Merus?
Merus NV is a clinical-stage immuno-oncology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.74B
P/E Ratio
N/A
Total Cash
537.03M
Projected Growth
N/A
Total Debt
9.91M
Revenue
36.13M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
7.77
Total Debt/Equity
N/A
Revenue/Share
0.56 USD as % of share price
Fundamentals
MRUS
Capitalization
2.74B
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
537M
Total Cash/Share
7.77
Total Debt
9.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.56%
Revenue
36.1M
ROE
N/A
Book Value
648M
P/B Ratio
4.49
Cash Flow
N/A
Earnings
-3.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.96M
Current Ratio
6.54
Current Revenue Per Employee
35153.85
Dividends Per Share - Security
N/A
EBITDA
-269.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.78
Shares Held By Institutions
4.2B
Shares Outstanding - Current
69.1M
Total Liabilities
135M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.826
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for cancer treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl